Literature DB >> 22130148

Clinical pain and experimental pain sensitivity in progressive supranuclear palsy.

Maria Stamelou1, Helena Dohmann, Juliane Brebermann, Evangelia Boura, Wolfgang H Oertel, Günter Höglinger, Jens C Möller, Veit Mylius.   

Abstract

OBJECTIVE: We aimed to assess spinal nociception and experimental pain sensitivity in progressive supranuclear palsy-Richardson's syndrome (PSP-R) compared to patients with Parkinson's disease (PD) and healthy controls (HC).
METHODS: Spinal nociception as measured by the nociceptive flexion reflex (NFR) and experimental pain sensitivity as measured by heat and electrical pain thresholds were determined in non-demented, non-depressed, probable PSP-R patients (N = 8), PD patients (N = 19) and 17 HC.
RESULTS: PSP-R patients exhibited lower electrical pain thresholds and a tendency for lower NFR thresholds as compared to HC. No significant differences between PSP-R and PD patients were found with respect to experimentally-induced pain. However, significantly less PSP-R than PD patients reported disease-related pain.
CONCLUSIONS: Degeneration of the descending inhibitory control system within the brainstem in PSP-R might lead to increased experimental pain sensitivity while frontal cortical deterioration may alter self-estimation of pain.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22130148     DOI: 10.1016/j.parkreldis.2011.11.010

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  7 in total

1.  Is increased spinal nociception another hallmark for Parkinson's disease?

Authors:  Evangelia Boura; Maria Stamelou; David Vadasz; Vincent Ries; Marcus M Unger; Georg Kägi; Wolfgang H Oertel; Jens C Möller; Veit Mylius
Journal:  J Neurol       Date:  2017-01-24       Impact factor: 4.849

2.  Pain in atypical parkinsonism, vascular parkinsonism, and Parkinson's disease.

Authors:  Young Hee Sung; Suk Yun Kang
Journal:  Neurol Sci       Date:  2022-03-26       Impact factor: 3.830

Review 3.  Towards optimising experimental quantification of persistent pain in Parkinson's disease using psychophysical testing.

Authors:  Rory V Smith; Patrick Wilkins; Kirsty Bannister; Tatum M Cummins
Journal:  NPJ Parkinsons Dis       Date:  2021-03-17

4.  Pain in multiple system atrophy and progressive supranuclear palsy compared to Parkinson's disease.

Authors:  Lewis Kass-Iliyya; Christopher Kobylecki; Kathryn R McDonald; Alexander Gerhard; Monty A Silverdale
Journal:  Brain Behav       Date:  2015-03-25       Impact factor: 2.708

5.  Characteristics of Nonmotor Symptoms in Progressive Supranuclear Palsy.

Authors:  Ruwei Ou; Wei Song; Qianqian Wei; Ke Chen; Bei Cao; Yanbing Hou; Bi Zhao; Huifang Shang
Journal:  Parkinsons Dis       Date:  2016-06-05

Review 6.  Pain in Neurodegenerative Disease: Current Knowledge and Future Perspectives.

Authors:  Marina de Tommaso; Lars Arendt-Nielsen; Ruth Defrin; Miriam Kunz; Gisele Pickering; Massimiliano Valeriani
Journal:  Behav Neurol       Date:  2016-06-05       Impact factor: 3.342

7.  Asymmetric, multifocal musculoskeletal pain preceding the onset of progressive supranuclear palsy: A case report.

Authors:  Yi Fang; Chong-Yao Jin; Ran Zheng; Ji-Min Wu; Bao-Rong Zhang; Jia-Li Pu
Journal:  CNS Neurosci Ther       Date:  2020-12-04       Impact factor: 5.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.